Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 29;17(4):498.
doi: 10.3390/v17040498.

Prevalence of Sexually Transmitted Infections Among Cisgender Women Coming to a Walk-In Center

Gaia Catalano  1 , Tommaso Clemente  2 , Sara Diotallevi  2 , Riccardo Lolatto  2 , Benedetta Trentacapilli  1 , Martina Ranzenigo  2 , Elena Bruzzesi  1   2 , Paola Cinque  1   3 , Antonella Castagna  1   2 , Silvia Nozza  1   2
Affiliations

Prevalence of Sexually Transmitted Infections Among Cisgender Women Coming to a Walk-In Center

Gaia Catalano et al. Viruses. .

Abstract

The general female population is not considered a high-risk group for screening for sexually transmitted infections (STIs). This retrospective study describes the prevalence of Human Immunodeficiency Virus (HIV), Treponema pallidum (T. pallidum), Chlamydia trachomatis (C. trachomatis), Neisseria gonorrhoeae (N. gonorrhoeae), Trichomonas vaginalis (T. vaginalis), Mycoplasma spp., Ureaplasma spp., genital Herpes simplex virus (HSV), Monkeypox (mpox), Hepatitis B virus (HBV), and Hepatitis C virus (HCV) infections in asymptomatic and symptomatic cisgender women attending our walk-in STI clinic for the first time. Furthermore, it analyzes the number of individuals who returned for follow-up and were diagnosed with new STIs. Over 20 months, 189 women with a median age of 28.4 years were screened [129 (68.3%) asymptomatic and 60 (31.8%) symptomatic]. In order of prevalence, the most common STIs were: Ureaplasma spp. infections (50.3%), C. trachomatis (10.6%), N. gonorrhoeae (5.8%), Mycoplasma hominis infections (5.8%), T. pallidum (2.65%), HSV2 infections (2.65%), and mpox (0.53%). No diagnosis of HIV, trichomoniasis, HBV, or HCV was registered. After the initial evaluation, 128 (67.7%) women returned for follow-up, but only 43 (22.8%) repeated screening; among them, 11 (25.6%) were diagnosed with new STIs. Given the high prevalence of STIs in cisgender women, awareness measures to improve screening and prevention strategies in this neglected population are required.

Keywords: HIV; STIs; hepatitis; prevention; sexual health; women’s health.

PubMed Disclaimer

Conflict of interest statement

We declare no competing interests related to this work. G.C. has no competing interests related to this work. T.C. has received personal fees for speaker panels from Gilead Sciences. S.D. has no competing interests related to this work. R.L has no competing interests related to this work. B.T. has no competing interests related to this work. M.R. has received personal fees for speaker panels from Tillots Pharma. E.B. has received personal fees for speaker panels from Gilead Sciences. P.C. has no competing interests related to this work. A.C. has received personal fees for advisory boards, speaker panels, and educational materials from Gilead Sciences, ViiV Healthcare, Janssen-Cilag, Merck Sharp & Dohme, and Theratechnologies. S.N. has received personal fees for advisory boards from Gilead Sciences and ViiV Healthcare, for speaker panels from Gilead Sciences, ViiV Healthcare, and Merck Sharp & Dohme, for meeting attendance from Gilead Sciences and Pfizer, and payments to her institution for consultancies from Gilead Sciences and ViiV Healthcare.

Figures

Figure 1
Figure 1
STIs screening flowchart for women coming to the San Raffaele walk-in center. * Performed only in the presence of suggestive lesions; # According to vaccination status.
Figure 2
Figure 2
Type of symptoms reported at baseline. # More than one symptom may have been reported by the same woman.
See this image and copyright information in PMC

References

    1. World Health Organization . Global Health Sector Strategies on, Respectively, HIV, Viral Hepatitis and Sexually Transmitted Infections for the Period 2022–2030. WHO; Geneva, Switzerland: 2022.
    1. European Centre for Disease Prevention and Control . A Systematic Review and Meta-Analysis of the Prevalence of Chlamydia, Gonorrhoea, Trichomoniasis and Syphilis in Europe. ECDC; Stockholm, Sweden: 2024.
    1. Salfa M.C., Ferri M., Suligoi B., Rete Sentinella dei Casi Clinici. Laboratori di Microbiologia clinica per le Infezioni Sessualmente Trasmesse Le Infezioni Sessualmente Trasmesse: Aggiornamento dei dati dei due Sistemi di Sorveglianza sentinella attivi in Italia al 31 dicembre 2021. Not. Ist. Super. Sanità. 2023;36:3–39.
    1. Workowski K.A., Bachmann L.H., Chan P.A., Johnston C.M., Muzny C.A., Park I., Reno H., Zenilman J.M., Bolan G.A. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm. Rep. 2021;70:1–187. doi: 10.15585/mmwr.rr7004a1. - DOI - PMC - PubMed
    1. Catalano G., Diotallevi S., Lolatto R., Trentacapilli B., Ranzenigo M., Bruzzesi E., Castagna A., Nozza S. P-128 Prevalence of sexually transmitted infections in cisgender women coming to walk-in center. Sex. Transm. Infect. 2024;100:A223–A224. - PubMed

LinkOut - more resources